Association of Chemotherapy for Solid Tumors With Development of Therapy-Related Myelodysplastic Syndrome or Acute Myeloid Leukemia in the Modern Era.
Ontology highlight
ABSTRACT: Importance:Therapy-related myelodysplastic syndrome or acute myeloid leukemia (tMDS/AML) is a rare, usually fatal complication of chemotherapy, including certain alkylating agents, topoisomerase II inhibitors, and platinum compounds. With the introduction of new chemotherapeutic agents, expanded indications for established agents, and increased neoadjuvant and adjuvant chemotherapy, tMDS/AML risks in the modern age are poorly understood. Objectives:To quantify tMDS/AML risk after chemotherapy for solid cancer among United States adults since 2000 and correlate tMDS/AML risk patterns with chemotherapy treatment practices. Design, Setting, and Participants:A population-based cohort study was conducted using cancer registries from the Surveillance, Epidemiology, and End Results (SEER) Program
SUBMITTER: Morton LM
PROVIDER: S-EPMC6439835 | biostudies-literature | 2019 Mar
REPOSITORIES: biostudies-literature
ACCESS DATA